Last updated : August 27, 2026 9:44 am
We have successfully created a differentiated continuous vapour-phase chlorination and fluorination capabilities, enabling us to serve both agrochemical and specialty chemical markets
One and a half years after rebranding from Sajjan India to Cohizon Life Sciences, how has the transformation into a technology-driven CDMO platform shaped the company’s strategic direction and long-term growth vision?
Over the past 18 months, Cohizon Life Sciences has accelerated its transformation into a technology-driven CDMO through investments in advanced chemistry platforms and differentiated technologies. While strengthening our leadership in CDMO agrochemicals with a richer portfolio of patented active ingredients, we are expanding into CDMO specialty chemicals and non-GMP pharmaceutical intermediates. Our vision is to be a leading pure play CDMO partners for global agrochemicals and specialty chemicals driven by innovation, lifecycle management expertise, and a strong performance-oriented culture.
How has the company performed in FY 2025-26 and what were the key growth drivers? Which product categories, chemistries, and market segments contributed most to the year's overall performance?
Despite continued pricing pressure in the global chemical market, Cohizon delivered improved profitability in FY 2025-26, through volume growth, product mix enhancement, and operational efficiencies. CDMO agrochemicals remained a major contributor, complemented by growing momentum in CDMO specialty chemicals segment. Our focus on differentiated chemistries, strong customer partnerships, and expanding pipeline of products positions us well for long-term value creation. Our relentless focus is on operational excellence, cost optimization, and process efficiencies significantly strengthened margins, while a healthy opportunity pipeline continues to support future growth.
The company has invested over Rs. 800 crore in fluorination, chlorination, and advanced R&D capabilities. How will these investments strengthen Cohizon’s positioning in high-value specialty chemicals and CDMO markets?
Cohizon has invested mainly to create new capacities, new technology platforms and to strengthen its manufacturing facilities, environment, and health & safety. We have successful created a differentiated continuous vapour-phase chlorination and fluorination capabilities, enabling us to serve both agrochemical and specialty chemical markets. Cohizon is the only company in the world to acquire and commercialize this unique technology platform. These investments strengthen customer retention, enhance our reputation as a technology-led partner, and position Cohizon as a one-stop CDMO solutions provider for complex and high-value chemistries. These investments have also helped us to on-board new customers and unlock opportunities translating into a stronger pipeline.
Cohizon has highlighted diversification beyond agrochemicals into various specialty chemicals segments viz. coating, electronics, personal care, etc. Which of these segments do you expect to become major growth drivers over the next few years?
Our diversification strategy is focused on building a balanced and resilient portfolio across high-growth, technology-driven segments. While agrochemicals will continue to remain an important pillar of our business, we see significant growth opportunities emerging in coating, electronic chemicals, personal care, flavour & fragrances and other specialty chemicals segments. Overall, we expect all four segments to contribute meaningfully to our future growth, with pharmaceuticals and specialty chemicals likely to emerge as the most significant drivers in the near to medium term, while electronic chemicals offer substantial long-term potential.
Agrochemical sector has faced inventory corrections and pricing pressure from China. How is Cohizon adapting its business strategy to navigate these industry-wide challenges?
The agrochemical industry has experienced a prolonged phase of inventory correction and pricing pressure over the last few years. We consider that now we have reached to a new normal of highly competitive pricing. While pricing remains competitive across several product categories, we have seen stabilization of volumes with nominal growth in demand on selected products compared to last year. At Cohizon, we are navigating this environment through a multi-pronged strategy focused on operational excellence, portfolio enhancement, and innovation-led growth. Our continuous improvement initiatives are driving cost optimization, productivity gains, and manufacturing efficiencies, helping us remain competitive despite pricing challenges. At the same time, we are steadily moving up the value chain by increasing our focus on differentiated, technology-intensive, and patented molecules under lifecycle management.
Our advanced R&D and CDMO capabilities enable us to develop customized solutions and build deeper, long-term partnerships with customers across global markets. In parallel, our investments in digital manufacturing, process innovation, and sustainability are strengthening our overall competitiveness and resilience. While near-term pricing pressures may persist, the improvement in volumes, combined with our focus on high-value products and customer-centric innovation, positions Cohizon well for sustainable and profitable long-term growth.
Cohizon is focusing heavily on fluorination and vapor phase chemistry capabilities. How important are these niche chemistry platforms in attracting global innovator companies and long-term contracts?
Fluorination and vapor-phase chemistry are highly strategic capabilities that play a critical role in attracting global innovator companies. These chemistries involve complex process engineering, stringent safety requirements, and significant capital investment, creating high entry barriers. Our advanced fluorination and chlorination platforms enable development and manufacture of several complex molecules used in agrochemicals and specialty chemicals products.
The company has implemented “Lakshya” initiative using lean manufacturing, six sigma, and digital interventions. What measurable operational improvements have emerged from this transformation program?
Program Lakshya launched about two years before is our flagship business excellence and transformation initiative. Through this cultural transformation journey, we are developing a new generation of certified lean six sigma green belt and black belt professionals who serve as catalysts for change—leading improvement initiatives, driving operational excellence, and helping transform our organization. Program Lakshya has delivered measurable benefits across product lines through initiatives focused on capacity enhancement, yield improvement, key raw material optimization, energy conservation, and waste reduction. A key outcome has been strengthened Business Continuity Planning (BCP), ensuring reliable and uninterrupted supply to customers even in volatile market conditions. These initiatives have also helped our customers remain competitive against generic and alternative sourcing options, while improving our ability to navigate China-led pricing pressure through better cost efficiency. Overall, Lakshya continues to reinforce our commitment to operational excellence and sustainable, resilient growth.
Cohizon has been investing in AI-driven yield optimization and digital manufacturing systems. How is digital transformation changing operational efficiency and customer responsiveness across Cohizon?
Cohizon continues to invest in AI and digital transformation as a strategic business capability. Our initial digital pilot has delivered measurable improvements in operational efficiency, productivity, cost optimization, and decision-making effectiveness. Encouraged by these outcomes, the organization is rapidly scaling digital adoption across business functions. This transformation is enhancing customer experience, strengthening competitiveness, supporting sustainability goals, and enabling sustainable long-term growth. Proactive, data-driven decision-making is enabling greater consistency and reliability across operations.
Sustainability appears to be a core pillar of the company’s strategy, with focus on water, waste, carbon, and energy management. What specific sustainability targets has Cohizon set for FY2026-27 and beyond?
Sustainability remains central to Cohizon’s long-term strategy with focus areas including carbon reduction, renewable energy integration, water conservation, waste minimization, and energy efficiency. The company is aligning its sustainability roadmap with global ESG expectations and Responsible Care principles. Guided by its "CARES" philosophy and alignment with the United Nations Sustainable Development Goals (SDGs), Cohizon Life Sciences treats environment, health, safety, and sustainability as a core business objective. Building on its baseline performance Cohizon has set the long term KPIs up to FY'30 focusing on: People and partnerships; Climate & environmental stewardship; Technology & innovation; and Governance & risk management. Cohizon’s structured sustainability roadmap is focusing directly on strategic priority i.e. Emission Intensity Scope 1 and 2 through 20 MW green/renewable power sourcing contract, reduce water withdrawal using 4R Approach (Recover, Reduce, Recycle, and Reuse) & reduce waste disposal.
The company recently signed a hybrid renewable energy agreement involving wind and solar power. Please talk about the deal? How will renewable energy integration help in reducing manufacturing costs and carbon footprint?
Cohizon recently signed a 20 MW renewable power sourcing contract (combines 19.8 MWac of wind capacity with a 19.2 MWac/25 MWp solar installation). The project is already started and generating clean electricity as a result we have reduced significant amount of greenhouse gas emissions. Beyond reducing our carbon footprint, renewable energy integration will provide greater energy cost stability, lower dependence on conventional power sources, and enhance our sustainability profile, which is increasingly important for global customers and supply chain partners.
How is the company strengthening its corporate social responsibility (CSR) initiatives and which areas of community development, sustainability, and healthcare access are currently a key focus area for the company?
At Cohizon Life Sciences, we are strengthening our CSR initiatives by investing in programs that create measurable and sustainable community impact. Our key focus areas include healthcare access, quality education, environmental sustainability, clean water, and rural development. In FY27, our CSR initiatives are expected to benefit over 25,000 people across 15 villages, 30 educational institutions, and 3 healthcare facilities. Aligned with the UN Sustainable Development Goals (SDGs), these efforts reflect our commitment to building healthier, empowered, and future-ready communities.